Carisma Therapeutics, Inc.Carisma Therapeutics, Inc.Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc.

No trades
See on Supercharts

Price target

1.000.000.00%
The 2 analysts offering 1 year price forecasts for CARM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to CARM in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CARM EPS for the last quarter is −0.25 USD despite the estimation of −0.22 USD. In the next quarter EPS is expected to reach −0.10 USD. Track more of Carisma Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Carisma Therapeutics, Inc. revenue is expected to reach ‪3.70 M‬ USD. Check out Carisma Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, CARM price target is 1.00 USD with a max estimate of 1.00 USD and a min estimate of 1.00 USD. Check if this forecast comes true in a year, meanwhile watch Carisma Therapeutics, Inc. stock price chart and keep track of the current situation with CARM news and stock market news.